Miltenyi Biotec and ShareLab invite the local science community to an afternoon dedicated to Cell Therapy and Immuno-oncology. Our CSO, Hugh Salter, will join this event and present Anocca’s platform for scaleable TCR-T cell therapy development.
Press release Apr 7, 2022Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory Board
Södertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms …
Press release Feb 22, 2022Anocca Appoints New Senior Management Roles and Expands Scientific Teams
Södertälje, Sweden, February 22, 2022 – Anocca AB, a pioneer in T cell immunotherapy, today …
Press release Sep 8, 2021Anocca appoints Jacob Michlewicz as CFO
Södertälje, Sweden, 8 September 2021 – Anocca AB, a leader in unlocking the potential of …